We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

51 hedge funds and large institutions have $12.1M invested in Greenwich LifeSciences in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 14

8% more capital invested

Capital invested by funds: $11.2M → $12.1M (+$909K)

0% more funds holding

Funds holding: 51 → 51 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.31% less ownership

Funds ownership: 9.21% → 8.91% (-0.31%)

Holders
51
Holders Change
–
Holders Change %
0%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
16
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$243K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$149K
3
Renaissance Technologies
Renaissance Technologies
New York
+$125K
4
Citadel Advisors
Citadel Advisors
Florida
+$81K
5
Goldman Sachs
Goldman Sachs
New York
+$37.8K

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$272K
2
Millennium Management
Millennium Management
New York
-$211K
3
HighTower Advisors
HighTower Advisors
Illinois
-$154K
4
Northern Trust
Northern Trust
Illinois
-$77.6K
5
BlackRock
BlackRock
New York
-$43.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFSG
26
Newbridge Financial Services Group
Florida
$20.9K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$12.7K -$22.4K -1,986 -61%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$12K +$6.59K +584 +90%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$11.3K +$5.62K +498 +78%
Legal & General Group
30
Legal & General Group
United Kingdom
$6.59K – – –
Russell Investments Group
31
Russell Investments Group
United Kingdom
$6.46K +$2.95K +261 +67%
AIP
32
Ameritas Investment Partners
Nebraska
$5.82K – – –
FCMT
33
Founders Capital Management (Texas)
Texas
$4.97K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$4.32K +$11 +1 +0.2%
Citigroup
35
Citigroup
New York
$2.64K -$21.5K -1,901 -88%
AB
36
Amalgamated Bank
New York
$2K – – –
WTA
37
Washington Trust Advisors
Massachusetts
$1.99K – – –
AAP
38
Arax Advisory Partners
Colorado
$1.22K +$1.39K +123 New
Carson Wealth (CWM LLC)
39
Carson Wealth (CWM LLC)
Nebraska
$1K +$11 +1 +2%
Optiver Holding
40
Optiver Holding
Netherlands
$955 +$1.08K +96 New
GWM
41
Geneos Wealth Management
Colorado
$876 – – –
NSIM
42
North Star Investment Management
Illinois
$507 – – –
HFS
43
Hopwood Financial Services
Virginia
$498 – – –
GRP
44
Global Retirement Partners
California
$448 – – –
EWA
45
EverSource Wealth Advisors
Alabama
$318 – – –
SS
46
SBI Securities
Japan
$299 – – –
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$289 +$327 +29 New
Nisa Investment Advisors
48
Nisa Investment Advisors
Missouri
$269 – – –
SCM
49
Sterling Capital Management
North Carolina
$149 +$11 +1 +7%
Osaic Holdings
50
Osaic Holdings
Arizona
$61 +$11 +1 +20%
1
2
3

GLSI Hedge Fund Activity: Q3 2025 in Review

51 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2025, worth a combined $12.1M — up 8.1% from $11.2M a quarter earlier.

Fund positioning in GLSI was balanced in Q3 2025: 5 funds opened new positions, 5 closed out, 16 added to existing stakes and 14 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $243K. The largest seller was Marshall Wace, cutting an estimated $272K.

  • 51 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $12.1M of Greenwich LifeSciences stock for Q3 2025, up 8.1% quarter-over-quarter.
  • 5 funds opened new Greenwich LifeSciences positions in Q3 2025 and 5 closed out, a net change of 0 holders.
  • The largest Greenwich LifeSciences buyer in Q3 2025 was Deutsche Bank, an estimated $243K added.
  • The largest Greenwich LifeSciences seller in Q3 2025 was Marshall Wace, an estimated $272K sold.

Based on aggregated 13F filings for Q3 2025.